Teladoc Health (NYSE:TDOC) Price Target Cut to $15.00 by Analysts at TD Cowen

Teladoc Health (NYSE:TDOC) had its price objective lowered by research analysts at TD Cowen from $16.00 to $15.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “hold” rating on the health services provider’s stock. TD Cowen’s target price suggests a potential upside of 13.72% from the stock’s previous close.

Several other equities research analysts also recently issued reports on the company. Leerink Partnrs reissued a “market perform” rating on shares of Teladoc Health in a research note on Monday, February 26th. Barclays reduced their price objective on Teladoc Health from $25.00 to $20.00 and set an “overweight” rating for the company in a research note on Friday. DA Davidson reduced their price objective on Teladoc Health from $22.00 to $18.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. Citigroup dropped their target price on Teladoc Health from $21.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 21st. Finally, Truist Financial dropped their target price on Teladoc Health from $23.00 to $17.00 and set a “hold” rating on the stock in a research report on Wednesday, March 6th. Eleven investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Teladoc Health has a consensus rating of “Hold” and a consensus target price of $20.00.

Teladoc Health Price Performance

Shares of Teladoc Health stock traded down $0.14 during trading on Friday, hitting $13.19. The stock had a trading volume of 4,457,614 shares, compared to its average volume of 4,756,420. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.54 and a quick ratio of 3.47. The firm has a market cap of $2.23 billion, a P/E ratio of -9.89 and a beta of 0.94. The business has a fifty day moving average of $15.17 and a two-hundred day moving average of $17.80. Teladoc Health has a fifty-two week low of $12.65 and a fifty-two week high of $30.41.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The company had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. During the same period in the prior year, the company earned ($0.37) earnings per share. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. On average, sell-side analysts expect that Teladoc Health will post -1.07 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Arnnon Geshuri sold 7,500 shares of Teladoc Health stock in a transaction on Monday, March 25th. The stock was sold at an average price of $15.06, for a total value of $112,950.00. Following the completion of the sale, the insider now directly owns 38,470 shares of the company’s stock, valued at approximately $579,358.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Arnnon Geshuri sold 7,500 shares of Teladoc Health stock in a transaction on Monday, March 25th. The stock was sold at an average price of $15.06, for a total transaction of $112,950.00. Following the completion of the sale, the insider now directly owns 38,470 shares of the company’s stock, valued at $579,358.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, COO Michael Willem Waters sold 4,523 shares of Teladoc Health stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total value of $86,751.14. Following the sale, the chief operating officer now directly owns 38,570 shares of the company’s stock, valued at $739,772.60. The disclosure for this sale can be found here. In the last ninety days, insiders sold 135,441 shares of company stock valued at $2,038,251. Company insiders own 1.63% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors have recently made changes to their positions in TDOC. Commonwealth Equity Services LLC lifted its holdings in Teladoc Health by 5.7% during the third quarter. Commonwealth Equity Services LLC now owns 80,934 shares of the health services provider’s stock worth $1,505,000 after acquiring an additional 4,344 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its holdings in Teladoc Health by 49.4% during the third quarter. Robeco Institutional Asset Management B.V. now owns 453,861 shares of the health services provider’s stock worth $8,437,000 after acquiring an additional 149,976 shares in the last quarter. Raymond James & Associates lifted its holdings in Teladoc Health by 0.9% during the third quarter. Raymond James & Associates now owns 228,238 shares of the health services provider’s stock worth $4,243,000 after acquiring an additional 2,029 shares in the last quarter. Mackenzie Financial Corp lifted its holdings in shares of Teladoc Health by 83.7% in the third quarter. Mackenzie Financial Corp now owns 30,843 shares of the health services provider’s stock valued at $570,000 after purchasing an additional 14,050 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in shares of Teladoc Health by 8.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 50,903 shares of the health services provider’s stock valued at $946,000 after purchasing an additional 4,129 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.